SCHEMBL5204034

SCHEMBL5204034

C=CCn1ccc(=O)c(OCc2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 7/20 0.46
APOBEC3G Q9HC16 1/20 0.41
HTT P42858 2/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
CCNB2 O95067 1/20 0.38
CDK1 P06493 1/20 0.38
CDK4 P11802 1/20 0.38
CCNB1 P14635 1/20 0.38
CCND1 P24385 1/20 0.38
CCNB3 Q8WWL7 1/20 0.38
ALOX15 P16050 1/20 0.38
SIRT1 Q96EB6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10671051 0.81 MAPK14 (0.47) MAPK14HTTMEN1ALDH1A1HPGD
SCHEMBL17128962 0.79 MAPK14 (0.42) MAPK14HTTMEN1ALDH1A1HPGD
SCHEMBL28378443 0.79 MAPK14 (0.42) MAPK14HTTMEN1ALDH1A1HPGD
SCHEMBL29067955 0.79 MAPK14 (0.48) MAPK14HTTMEN1ALDH1A1HPGD
SCHEMBL17695114 0.78 MAPK14 (0.41) MAPK14HTTMEN1ALDH1A1HPGD
SCHEMBL12949898 0.78 MAPK14 (0.41) MAPK14HTTMEN1ALDH1A1HPGD
SCHEMBL12949559 0.78 MAPK14 (0.41) MAPK14HTTMEN1ALDH1A1HPGD
SCHEMBL2115729 0.75 MAPK14 (0.51) MAPK14HTTMEN1ALDH1A1HPGD
SCHEMBL30982580 0.75 TLR4 (0.45) MAPK14APOBEC3GHTTMEN1ALDH1A1
SCHEMBL30982887 0.75 TLR4 (0.45) MAPK14APOBEC3GHTTMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1039804-A4 METHOD FOR TREATING FIBROPROLIFERATIVE DISORDERS BY INHIBITORS OF PROTEIN HYDROXYLATION CORNELL RES FOUNDATION INC (US) 2007-08-08 EP disclosed
WO-2004005321-A2 METHODS OF INHIBITING 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE IN A LIVING SYSTEM THE ROCKEFELLER UNIVERSITY (US) 2004-01-15 WO disclosed
EP-0808103-A4 PROTEIN HYDROXYLATION INHIBITORS FOR FIBROPROLIFERATIVE DISORDERS CORNELL RES FOUNDATION INC (US) 2001-10-17 EP disclosed
WO-2001017497-A1 DEPIGMENTING COMPOSITIONS GHISALBERTI CARLO (BR) 2001-03-15 WO disclosed
EP-1039804-A1 METHOD FOR TREATING FIBROPROLIFERATIVE DISORDERS BY INHIBITORS OF PROTEIN HYDROXYLATION CORNELL RESEARCH FOUNDATION, INC. (US) 2000-10-04 EP disclosed
EP-0831876-A4 METHOD OF INHIBITING VIRAL REPLICATION IN EUKARYOTIC CELLS AND OF INDUCING APOPTOSIS OF VIRALLY-INFECTED CELLS CORNELL RES FOUNDATION INC (US) 2000-08-30 EP disclosed
WO-1999030562-A1 METHOD FOR TREATING FIBROPROLIFERATIVE DISORDERS BY INHIBITORS OF PROTEIN HYDROXYLATION CORNELL RESEARCH FOUNDATION, INC. (US) 1999-06-24 WO disclosed
EP-0831876-A1 METHOD OF INHIBITING VIRAL REPLICATION IN EUKARYOTIC CELLS AND OF INDUCING APOPTOSIS OF VIRALLY-INFECTED CELLS CORNELL RESEARCH FOUNDATION, INC. (US) 1998-04-01 EP disclosed
EP-0808103-A1 PROTEIN HYDROXYLATION INHIBITORS FOR FIBROPROLIFERATIVE DISORDERS CORNELL RESEARCH FOUNDATION, INC. (US) 1997-11-26 EP disclosed
WO-1996041639-A1 METHOD OF INHIBITING VIRAL REPLICATION IN EUKARYOTIC CELLS AND OF INDUCING APOPTOSIS OF VIRALLY-INFECTED CELLS CORNELL RESEARCH FOUNDATION, INC. (US) 1996-12-27 WO disclosed
WO-1996022021-A1 PROTEIN HYDROXYLATION INHIBITORS FOR FIBROPROLIFERATIVE DISORDERS CORNELL RESEARCH FOUNDATION, INC. (US) 1996-07-25 WO disclosed